BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23221959)

  • 1. Truncated dystrophins reduce muscle stiffness in the extensor digitorum longus muscle of mdx mice.
    Hakim CH; Duan D
    J Appl Physiol (1985); 2013 Feb; 114(4):482-9. PubMed ID: 23221959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The passive mechanical properties of the extensor digitorum longus muscle are compromised in 2- to 20-mo-old mdx mice.
    Hakim CH; Grange RW; Duan D
    J Appl Physiol (1985); 2011 Jun; 110(6):1656-63. PubMed ID: 21415170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.
    Lindsay A; Larson AA; Verma M; Ervasti JM; Lowe DA
    J Appl Physiol (1985); 2019 Feb; 126(2):363-375. PubMed ID: 30571283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen content does not alter the passive mechanical properties of fibrotic skeletal muscle in mdx mice.
    Smith LR; Barton ER
    Am J Physiol Cell Physiol; 2014 May; 306(10):C889-98. PubMed ID: 24598364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model.
    Rodino-Klapac LR; Janssen PM; Shontz KM; Canan B; Montgomery CL; Griffin D; Heller K; Schmelzer L; Handy C; Clark KR; Sahenk Z; Mendell JR; Kaspar BK
    Hum Mol Genet; 2013 Dec; 22(24):4929-37. PubMed ID: 23863459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable rescue of microtubule and physiological phenotypes in mdx muscle expressing different miniaturized dystrophins.
    Nelson DM; Lindsay A; Judge LM; Duan D; Chamberlain JS; Lowe DA; Ervasti JM
    Hum Mol Genet; 2018 Jun; 27(12):2090-2100. PubMed ID: 29618008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myofibrillar Lattice Remodeling Is a Structural Cytoskeletal Predictor of Diaphragm Muscle Weakness in a Fibrotic
    Ritter P; Nübler S; Buttgereit A; Smith LR; Mühlberg A; Bauer J; Michael M; Kreiß L; Haug M; Barton E; Friedrich O
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.
    Harper SQ; Hauser MA; DelloRusso C; Duan D; Crawford RW; Phelps SF; Harper HA; Robinson AS; Engelhardt JF; Brooks SV; Chamberlain JS
    Nat Med; 2002 Mar; 8(3):253-61. PubMed ID: 11875496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
    Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
    Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury.
    Liu M; Yue Y; Harper SQ; Grange RW; Chamberlain JS; Duan D
    Mol Ther; 2005 Feb; 11(2):245-56. PubMed ID: 15668136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy.
    Carberry S; Brinkmeier H; Zhang Y; Winkler CK; Ohlendieck K
    Int J Mol Med; 2013 Sep; 32(3):544-56. PubMed ID: 23828267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
    Wasala NB; Bostick B; Yue Y; Duan D
    Hum Mol Genet; 2013 Jul; 22(13):2634-41. PubMed ID: 23459935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function.
    Chu X; Li J; Qiao C; Wang J; Wang Y; Jiang XC; You H; Xiao X; Wang B
    FASEB J; 2021 Jun; 35(6):e21628. PubMed ID: 33982338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice.
    Bostick B; Yue Y; Long C; Marschalk N; Fine DM; Chen J; Duan D
    Mol Ther; 2009 Feb; 17(2):253-61. PubMed ID: 19066599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.
    Capogrosso RF; Mantuano P; Uaesoontrachoon K; Cozzoli A; Giustino A; Dow T; Srinivassane S; Filipovic M; Bell C; Vandermeulen J; Massari AM; De Bellis M; Conte E; Pierno S; Camerino GM; Liantonio A; Nagaraju K; De Luca A
    FASEB J; 2018 Feb; 32(2):1025-1043. PubMed ID: 29097503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.